41. 巨細胞性動脈炎 Giant cell arteritis Clinical trials / Disease details

臨床試験数 : 131 / 薬物数 : 139 - (DrugBank : 36) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 125

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03026504 (ClinicalTrials.gov)	March 9, 2017	17/1/2017	Baricitinib in Relapsing Giant Cell Arteritis	Baricitinibin Relapsing Giant Cell Arteritis (GCA): A Phase II, Single-institution, Open-label Pilot ...	Arteritis, Giant Cell	Drug: Baricitinib	Matthew J Koster	Eli Lilly and Company	Completed	50 Years	N/A	All	15	Phase 2	United States